Studies have showed that sustained innate IL-25 signaling helped to maintain the cancer permissive microenvironment of colorectal adenocarcinoma by preventing anti-tumor T cells and IFNγ-mediated immunity 17. This evidence concerns the gene IL25 and cancer.